7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Cancer of Pancreas

7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Q; Cui, Y; Gao, YT; Lan, Q; Li, HL; Rothman, N; Shu, XO; Wen, W; Xiang, YB; Yang, G; Yin, HY; Zheng, W	1

Other Studies

1 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Cancer of Pancreas

Article	Year
Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk. International journal of cancer, 2017, 12-15, Volume: 141, Issue:12 Topics: Adult; Aged; Body Mass Index; Case-Control Studies; China; Chromatography, Liquid; Cyclooxygenase 2; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Pancreatic Neoplasms; Prospective Studies; Prostaglandins; Tandem Mass Spectrometry	2017

Article

Year

Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.

International journal of cancer, 2017, 12-15, Volume: 141, Issue:12

Topics: Adult; Aged; Body Mass Index; Case-Control Studies; China; Chromatography, Liquid; Cyclooxygenase 2; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Pancreatic Neoplasms; Prospective Studies; Prostaglandins; Tandem Mass Spectrometry

2017